Analysts have nudged Teva Pharmaceutical's fair value estimate upward but tightened their valuation ranges, reflecting a guarded optimism as the company's pipeline developments through 2026 face scrutiny against a modest revenue growth forecast.
NGL Energy Partners (NGL) reported robust quarterly results, featuring record water disposal volumes and significant adjusted EBITDA growth. The partnership's units have surged over 20% in the past month, prompting investors to question if the stock still holds value after its impressive run.
French biotech ABIVAX reports positive Phase 3 results for its lead drug obefazimod in ulcerative colitis, meeting key secondary endpoints with a clean safety profile. With funding secured through late 2027, the company plans to advance pivotal maintenance and Crohn's disease trials, reshaping its investment narrative.
USA Rare Earth lands a pivotal role in America's critical minerals strategy, securing a potential $1.6 billion federal package and new private investment to build a domestic supply chain from mine to magnet.
ADP reported strong quarterly earnings and raised its full-year guidance, while unveiling new AI-powered 'Assist' agents designed to automate HR and payroll tasks. The move highlights the company's strategy to monetize its vast employment dataset, even as investors question its growth trajectory and the costs of AI integration.
PAR Technology's shares have plummeted over 68% in the past year, raising critical questions about its future. While a discounted cash flow model suggests deep undervaluation, other metrics paint a more complex picture. Investors are left weighing the stark disconnect between the company's software potential and its market performance.
Axsome Therapeutics' preliminary 2025 results reveal blockbuster-level sales for its depression drug Auvelity, while investor focus intensifies on its potential FDA label expansion for Alzheimer's disease agitation—a move that could redefine the company's valuation and pipeline prospects.
Shares of business process outsourcing giant Genpact (NYSE: G) have tumbled 15% in the past month, reigniting a debate among analysts over whether the sell-off presents a buying opportunity or reflects deeper challenges in its legacy operations and IT services segments.
Polkadot's long-awaited native smart contract capability is now live, aiming to lure Ethereum developers with familiar tooling. Despite a slow start with just 19 contracts deployed in the first week, the team behind the $2.4 billion blockchain emphasizes a focus on building a robust foundation over chasing immediate metrics.
South Bow (TSX:SOBO) is walking a tightrope, balancing a lucrative dividend payout with an aggressive debt-reduction plan. With its flagship Blackrod Project nearing completion, the Calgary-based energy firm faces both opportunity and constraint in Western Canada's pipeline network.
Elon Musk's social media platform X is under unprecedented global scrutiny, with recent controversies over its AI chatbot Grok and content moderation policies prompting regulatory actions and penalties that threaten its core business model and future ambitions.
An internal Justice Department review has found that attorney Ed Martin, a Trump appointee, improperly shared grand jury materials related to investigations of political figures. The findings led to his removal from a key role and eventual departure from the department.
As U.S. and Iranian officials prepare for high-stakes talks, a series of dangerous aerial and naval incidents in the Gulf underscores the fragile line between diplomacy and escalation. Analysts warn President Trump's threats face a critical credibility test, drawing inevitable parallels to a previous administration's pivotal moment.
The man accused of killing one D.C. National Guard member and critically wounding another in a November attack near the White House has pleaded not guilty to federal charges including first-degree murder.
A 2020 interview depicting William Stevenson as a devoted husband now stands in stark contrast to his arrest for the alleged murder of his wife, Linda, casting a grim shadow over a figure connected to the First Family.
The U.S. Supreme Court has declined to block California's newly drawn congressional districts, a decision that bolsters Democratic prospects to gain up to five House seats in the upcoming elections and intensifies the national battle over partisan redistricting.
Senator Tim Scott pushes back against a Justice Department investigation into Fed Chair Jerome Powell, calling it a political maneuver that is now jeopardizing the confirmation of President Trump's nominee to succeed Powell.
While surging electricity demand from AI data centers grabs headlines, GE Vernova's robust performance across natural gas, renewables, and grid services suggests a broader, more sustainable growth trajectory for the energy infrastructure leader.
Despite a recent 11% weekly slide, shares of Duos Technologies Group (NASDAQ: DUOT) have delivered a staggering 91% return to shareholders over the past three years, dramatically outperforming the broader market. The rally comes even as the company's revenue has contracted, highlighting a disconnect that has analysts urging caution.
The Texas-based independent theater chain has abruptly closed its entire Los Angeles footprint, the latest blow to an industry still grappling with post-pandemic recovery and shifting audience habits.
